---
title: "Sudeep Pharma Ltd (SUDEEPPHRM) — Share Price, Financials & Analysis"
symbol: "SUDEEPPHRM"
company: "Sudeep Pharma Ltd"
canonical: "https://tapetide.com/stocks/SUDEEPPHRM"
isin: "INE0QPI01025"
nse_symbol: "SUDEEPPHRM"
bse_code: "544619"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
market_cap_cr: 13413.78
generated_at: "2026-09-13T19:10:14.411Z"
---

# Sudeep Pharma Ltd (SUDEEPPHRM)

Canonical page: https://tapetide.com/stocks/SUDEEPPHRM

## Company

- **NSE Symbol:** SUDEEPPHRM
- **BSE Code:** 544619
- **ISIN:** INE0QPI01025
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2025-11-28
- **Face Value:** ₹1
- **F&O Eligible:** No
- **Website:** sudeeppharma.com

## About

Incorporated in 1989, Sudeep Pharma Limited is a manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients serving over 100 countries.[1]

## Latest Price

- **Price:** ₹1202.8
- **Change:** -10.7 (-0.88%)
- **Open:** ₹1152.9
- **Day High:** ₹1244
- **Day Low:** ₹1152.9
- **Previous Close:** ₹1213.5
- **Volume:** 593341
- **As Of:** 2026-09-11T10:24:14+00:00

## Key Fundamentals

Observed at 2026-09-11T04:47:23.049251Z.

- **Market Cap:** ₹13413.78 Cr
- **Classification:** Microcap
- **P/E (reported):** 74.6
- **P/E (TTM):** 71.47
- **EPS (TTM):** ₹16.83
- **Book Value:** ₹78.21
- **Price to Book:** 15.5
- **Dividend Yield:** 0.12%
- **ROE:** 19.41%
- **ROCE:** 24.22%
- **Debt to Equity:** 0.17
- **Revenue (yearly):** ₹670.8 Cr
- **Net Income:** ₹174.3 Cr
- **EBITDA:** ₹250.5 Cr
- **52-Week High:** ₹1378
- **52-Week Low:** ₹524.05
- **RSI (14):** 58.11

## Key Insights

### Strengths

- Company has delivered good profit growth of 39.0% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 31.8%

### Weaknesses

- Stock is trading at 15.4 times its book value

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 42.73% | 5.88% | — |
| ebitda margin growth | -12.46% | -4.18% | -7.44% | 74.81% |
| net income growth | -16.29% | 25.67% | 40% | 39% |
| revenue growth | -13.29% | 31.19% | 14% | 24% |
| roce | -13.48% | -30.38% | -48.97% | 35.72% |
| roe | -16.38% | -31% | 28.32% | -36.8% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 149 | 116 | 158 | 125 | 163 | 172 | 182 | 158 |
| Expenses | 85 | 76 | 99 | 81 | 107 | 112 | 120 | 103 |
| Operating Profit | 63 | 39 | 59 | 44 | 55 | 60 | 63 | 55 |
| OPM % | 43 | 34 | 37 | 35 | 34 | 35 | 34 | 35 |
| Other Income | 2 | 2 | 4 | 5 | 10 | 7 | 6 | 5 |
| Interest | 1 | 1 | 2 | 2 | 2 | 1 | 2 | 2 |
| Depreciation | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 |
| Profit before tax | 62 | 38 | 58 | 44 | 60 | 62 | 63 | 54 |
| Tax % | 21 | 24 | 24 | 29 | 21 | 23 | 23 | 25 |
| Net Profit | 49 | 29 | 44 | 31 | 47 | 48 | 49 | 41 |
| EPS in Rs | 128.13 | 2.95 | 4.54 | 3.17 | 4.71 | 4.2 | 4.33 | 3.59 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 123 | 215 | 343 | 429 | 459 | 502 | 642 | 676 |
| Expenses | 98 | 171 | 276 | 338 | 276 | 310 | 419 | 443 |
| Operating Profit | 25 | 44 | 67 | 90 | 183 | 192 | 223 | 233 |
| OPM % | 21 | 20 | 20 | 21 | 40 | 38 | 35 | 34 |
| Other Income | 3 | 3 | 7 | 9 | 6 | 9 | 28 | 29 |
| Interest | 1 | 1 | 2 | 6 | 5 | 7 | 8 | 8 |
| Depreciation | 3 | 4 | 5 | 8 | 9 | 11 | 15 | 16 |
| Profit before tax | 25 | 43 | 69 | 86 | 175 | 183 | 228 | 238 |
| Tax % | 27 | 22 | 27 | 28 | 24 | 24 | 24 | — |
| Net Profit | 18 | 33 | 50 | 62 | 133 | 139 | 174 | 184 |
| EPS in Rs | 128.02 | 236.6 | 356.04 | 442.27 | 945.21 | 14.27 | 15.31 | 16.83 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 1 | 1 | 1 | 1 | 1 | 10 | 11 |
| Reserves | 80 | 113 | 162 | 222 | 355 | 481 | 872 |
| Borrowings | 20 | 31 | 84 | 83 | 78 | 140 | 150 |
| Other Liabilities | 30 | 67 | 97 | 113 | 80 | 86 | 141 |
| Total Liabilities | 131 | 213 | 344 | 420 | 514 | 717 | 1174 |
| Fixed Assets | 60 | 68 | 137 | 158 | 180 | 189 | 337 |
| CWIP | 8 | 24 | 8 | 26 | 45 | 88 | 185 |
| Investments | 6 | 19 | 0 | 3 | 0 | 0 | 0 |
| Other Assets | 57 | 102 | 199 | 232 | 289 | 439 | 652 |
| Total Assets | 131 | 213 | 344 | 420 | 514 | 717 | 1174 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 10 | 35 | -3 | 48 | 66 | 49 | 70 |
| Cash from Investing Activity | -22 | -40 | -38 | -50 | -49 | -79 | -327 |
| Cash from Financing Activity | 12 | 13 | 51 | -10 | -13 | 53 | 247 |
| Net Cash Flow | 0 | 8 | 10 | -11 | 4 | 23 | -10 |
| Free Cash Flow | 1 | 24 | -77 | 1 | 13 | -15 | -49 |
| CFO/OP | 62 | 104 | 22 | 78 | 60 | 47 | 56 |

### Ratios

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 90 | 94 | 114 | 80 | 115 | 135 | 129 |
| Inventory Days | 77 | 79 | 104 | 142 | 147 | 309 | 356 |
| Days Payable | 70 | 79 | 76 | 77 | 112 | 145 | 113 |
| Cash Conversion Cycle | 97 | 93 | 142 | 145 | 150 | 298 | 372 |
| Working Capital Days | 46 | 13 | 30 | 92 | 99 | 144 | 175 |
| ROCE % | — | 36 | 36 | 33 | 49 | 36 | 28 |

## Shareholding Pattern

### Quarterly

| Category | Jun 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- |
| Promoters | 91.07% | 76.15% | 76.15% | 76.15% |
| FIIs | 0% | 1.67% | 1.55% | 1.81% |
| DIIs | 0% | 17.6% | 18.11% | 15.65% |
| Government | 0% | 0% | 0% | 0% |
| Public | 0% | 3.27% | 3.11% | 4.89% |
| Others | 8.93% | 1.31% | 1.07% | 1.5% |
| No. of Shareholders | 16 | 43599 | 36503 | 35695 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Buy
- **Buy / Neutral / Sell:** 9 / 7 / 3

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 1265.78 | Sell |
| EMA (10) | 1241.87 | Sell |
| SMA (20) | 1195.66 | Buy |
| EMA (20) | 1192.85 | Buy |
| SMA (50) | 1018.31 | Buy |
| EMA (50) | 1060.23 | Buy |
| SMA (100) | 877.41 | Buy |
| EMA (100) | 933.23 | Buy |
| SMA (200) | — | Neutral |
| EMA (200) | — | Neutral |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 56.48 | Neutral |
| MACD (12,26,9) | 71.93 | Sell |
| Stochastic (14,3,3) | 46.55 | Neutral |
| ADX (14) | 71.49 | Buy |
| Williams %R (14) | -63.85 | Neutral |
| ATR (14) | 61.22 | High Volatility |
| ROC (12) | 6.53 | Buy |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 44.37 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 0 | 0% |
| Hold | 1 | 50% |
| Sell | 1 | 50% |

Based on 2 analyst ratings, observed at 2026-09-11T04:47:24.744824+00:00.

## Filings & Documents

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-08-11 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f29ff0d0-c3a3-4405-a340-4f726c5d6844.pdf) |
| 2026-05-28 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3cc454a-9c93-4e22-a4a6-9b9cc27aa715.pdf) |
| 2026-02-12 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41aeb393-acbf-4a0a-a2e8-9b0587abebd2.pdf) |

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-06 | [General Update](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cadd2ed9-2514-445c-99bc-8bdddfe0dec3.pdf) |
| 2026-08-05 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=82b33a7c-de92-4c81-b58f-fd7034cc94a7.pdf) |
| 2026-08-05 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e35139a7-b551-4545-84be-1a315f8b7715.pdf) |
| 2026-08-04 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e329ead3-d0e8-4559-881b-2516ed3c733e.pdf) |
| 2026-08-04 | [Board Meeting Outcome for Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2d2ebdb7-fa01-44ff-86e6-2fc6f548a3cf.pdf) |
| 2026-07-29 | [Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=D46CE539_DFA6_4EC5_B874_D7FADE74E66C_101755.pdf) |
| 2026-07-27 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dc7e89c3-990e-443e-8b51-755e9f1877ff.pdf) |
| 2026-07-25 | [Board Meeting Intimation for Adoption Of Unaudited Financials (Standalone & Consolidated) For The Quarter Ended 30Th June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a019b46c-a72a-4385-a236-fa167bb861ff.pdf) |
| 2026-07-11 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4921501-b8a2-4012-8b74-e81dc9c8c2d9.pdf) |
| 2026-07-10 | [Notice Of 37Th Annual General Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6ccc0b07-f2f4-43dc-8659-5f94d8b58cd1.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-08-05 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9d228d0d-dffb-4b1b-83a1-8c27c73beb1b.pdf) |
| 2026-05-22 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=185d172c-b617-4ae3-a7b2-89a22ef4b4db.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-04 | [Unaudited Financials As On 30.06.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=100883ae-8bc1-49a3-b071-e7fd87aa884e.pdf) |
| 2026-05-21 | [Submission Of Financial Results For The Year Ended 31St March 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=67bc0104-36d7-42a4-b93e-3f1e2d2e9fc1.pdf) |
| 2026-02-06 | [Un-Audited Financial Results As On 31.12.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=43624ae0-8d39-4285-a1ba-7a2897b3e399.pdf) |
| 2025-12-19 | [Submission Of Financials As On Quarter And Half Year Ended 30Th September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0e2a50b4-4553-414a-af0d-a16052de4276.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-04 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8f04dc87-b6fc-40c9-89a9-414d4bc53ec2.pdf) |
| 2026-08-04 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c09feed-5195-43e7-9704-2d306e1e1b90.pdf) |
| 2026-08-04 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=db060038-94d4-45c9-9c24-a9dbc64452cd.pdf) |
| 2026-05-21 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9f549ff9-9f5c-4191-b616-88aa7db7104c.pdf) |
| 2026-02-07 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ddd9338d-355f-4f2f-9c70-3d3d0095a3f5.pdf) |
| 2025-12-21 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8e62e087-62c8-4fa5-a09e-1f9b488bd0fd.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f3cc454a-9c93-4e22-a4a6-9b9cc27aa715.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/f3cc454a-9c93-4e22-a4a6-9b9cc27aa715.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9f549ff9-9f5c-4191-b616-88aa7db7104c.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/9f549ff9-9f5c-4191-b616-88aa7db7104c.pdf) |
| Dec 2025 | [Concall - Dec 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e2336f1-2194-4ede-b4e5-ea6400cafbfa.pdf) |
| Dec 2025 | [Concall - Dec 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6e2336f1-2194-4ede-b4e5-ea6400cafbfa.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Feb - Audio recording of Q3 FY2026 earnings call uploaded; transcript forthcoming. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 9 Feb - Audio recording of Q3 FY2026 earnings call uploaded; transcript forthcoming.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8567d169-f764-4027-a588-487ce0d304af.pdf) |
| 9 Feb - Audio recording of Q3 FY2026 earnings call (09 Feb 2026) uploaded; transcript forthcoming. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 9 Feb - Audio recording of Q3 FY2026 earnings call (09 Feb 2026) uploaded; transcript forthcoming.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c79912f5-f633-4e7e-9569-68e1bed6c323.pdf) |
| 26 Mar - Trading window closed from 1 Apr 2026 until 48 hours after FY2026 audited results declaration. | [Closure of Trading Window 26 Mar - Trading window closed from 1 Apr 2026 until 48 hours after FY2026 audited results declaration.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6855fed7-087a-4bd8-8cc9-401c2eea0b0c.pdf) |
| — | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 10 Apr](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2ffdc170-ff69-4f5f-9c51-f354b42458bc.pdf) |
| — | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 17 Mar](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4d3c1d4b-74d0-4a64-9e9c-6e98f9a249e4.pdf) |
| — | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript 12 Feb](https://www.bseindia.com/xml-data/corpfiling/AttachHis/41aeb393-acbf-4a0a-a2e8-9b0587abebd2.pdf) |
| — | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 7 Feb](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0c9c07df-03f8-444d-ab7b-653de92b591b.pdf) |
| — | [Announcement under Regulation 30 (LODR)-Investor Presentation 7 Feb](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ddd9338d-355f-4f2f-9c70-3d3d0095a3f5.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/84a053c8-1286-4773-8974-5ec2e053c1cc.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:10:14.411Z.